This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Press Releases
Non-regulatory
Regulatory
Interim Report Q1 – January – March, 2022 Redsense Medical AB (publ)
Regulatory
Redsense Medical AB (publ) årsredovisning 2021
Regulatory
KALLELSE TILL ÅRSSTÄMMA I REDSENSE MEDICAL AB (PUBL)
Non-regulatory
New MHRA Guidance acknowledges the need to monitor for VND
Non-regulatory